Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Caribou Biosciences, Inc. (CRBU) had Tangible Shareholders Equity of $122.17M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$3.94M |
|
$-26.49M |
|
-- |
|
$3.94M |
|
$32.39M |
|
$-28.45M |
|
$1.42M |
|
$-27.04M |
|
$-27.04M |
|
$-26.49M |
|
$-26.49M |
|
$-26.49M |
|
$-26.45M |
|
$-28.45M |
|
$-27.93M |
|
93.39M |
|
93.39M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$145.23M |
|
$6.76M |
|
$30.14M |
|
$175.37M |
|
$25.41M |
|
-- |
|
$27.78M |
|
$53.19M |
|
$122.17M |
|
|
Tangible Shareholders Equity |
$122.17M |
$122.17M |
|
95.14M |
|
| Cash Flow Statement Financials | |
$-110.99M |
|
$102.24M |
|
$4.82M |
|
$16.34M |
|
$12.41M |
|
$-3.93M |
|
$12.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-721.97% |
|
-721.97% |
|
-- |
|
-686.07% |
|
-672.11% |
|
$-112.35M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
2.00 |
|
45.06 |
|
-21.68% |
|
-21.68% |
|
-15.10% |
|
-21.68% |
|
$1.28 |
|
$-1.20 |
|
$-1.19 |
|